Physician

Robert David Kemp, MD

According to 2025 Medicare claims, Robert Kemp, MD (NPI: 1932293131) practices nephrology in the Goldsboro, NC market, with the plurality of this provider's patient population coming from Wayne, NC. This provider's primary affiliated billing organization is CAROLINA NEPHROLOGY PA (NPI: 1659411924; TIN: 562125448) and primary practice location at 27534-2240.

Kemp's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 211 traditional Medicare patients, billed 904 HCPCS/CPT codes, and received $114,977 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 835 prescription claims across 165 beneficiaries totaling $28,659 in drug costs, led by Sevelamer Carbonate (Sevelamer Carbonate). DME data shows 34 claims. Open Payments data shows 1 records totaling $32. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $298,527 to $114,977. Similarly, Part D prescription costs have declined steadily, from $598,952 to $28,659. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $9,138 to $1,294.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	720	4,265	$298,527
2016	715	4,686	$381,886
2017	671	4,177	$344,962
2018	680	3,657	$286,836
2019	620	3,247	$251,087
2020	536	2,430	$226,687
2021	428	1,635	$174,059
2022	392	1,453	$151,285
2023	325	1,298	$148,974
2024	211	904	$114,977

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	304	3,669	$598,952
2016	288	3,097	$397,389
2017	305	3,238	$859,983
2018	298	3,189	$298,219
2019	310	3,126	$301,874
2020	274	2,255	$161,184
2021	242	1,867	$135,182
2022	206	1,409	$118,621
2023	202	1,120	$84,374
2024	165	835	$28,659

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	31	196	$6,475
2016	16	102	$1,282
2017	11	101	$1,493
2018	N/R	94	$2,234
2019	N/R	67	$956
2020	N/R	N/R	N/R
2021	N/R	45	$1,546
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	34	$911

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	47	159	$258
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	45	58	$129
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	39	39	$115
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	58	169	$88
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	97	165	$65

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Sevelamer Carbonate	Sevelamer Carbonate	37	1,593	$4,852
Calcitriol	Calcitriol	222	10,911	$3,478
Valsartan	Valsartan	92	4,429	$1,120
Cinacalcet Hcl	Cinacalcet Hcl	16	1,020	$958
Losartan Potassium	Losartan Potassium	42	2,435	$735

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7518	Mycophenolic acid, oral, 180 mg	N	N/R	12	$598
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	22	$314

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$32	Fresenius USA Marketing, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Robert David Kemp, MD?

Tedicare shows public-source Medicare data for Robert David Kemp, MD (NPI 1932293131), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert David Kemp, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Robert David Kemp, MD?

Robert David Kemp, MD is linked to CAROLINA NEPHROLOGY PA (billing NPI 1659411924) in the available physician profile data.

Does Robert David Kemp, MD have Open Payments data?

Robert David Kemp, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.